drugset / Trial / NCT03647982
Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers
Non-randomizedParallel-groupDouble-blindTreatment
Summary
To determine the anhidrotic area and safety of MEDITOXIN
Timeline
- Start
- 2018-03-20
- Primary completion
- 2018-10-20
- Completion
- 2018-11-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 1 iu | Other |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 3 iu | Other |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 5 iu | Other |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 10 iu | Other |